Literature DB >> 530491

Endogenous brain angiotensin II disrupts passive avoidance behavior in rats.

M Köller, H P Krause, F Hoffmeister, D Ganten.   

Abstract

The presence of angiotensinogen, the precursor of angiotensin II (ANG II), in brain tissue and in cerebrospinal fluid (CSF) allows stimulation of endogenous brain ANG II by renin. Passive avoidance tests were performed in female Wistar rats. The animals received an electrical shock after entering a black box on the first experimental day. Avoidance was tested every 24 h for 5 consecutive days. Renin in doses of 0.01 and 0.1 units was injected once into the lateral brain ventricles 2 min before the first test. CSF ANG II increased from 40 to 4547 and 5152 fmol per ml (means), respectively. A dose-dependent disruption of avoidance learning was observed, the frequency to enter the black box increasing from 11% (control) to 29% and 46%, and the latency decreasing from 165 (control) to 143 and 116 sec, respectively. These effects were statistically significant (P less than 0.001) for more than 24 h and returned to control levels after 48 to 120 h. Administration of the converting-enzyme inhibitor SQ 14225 i.v.t. prior to renin injections abolished the renin effects. Injections of renin given 22 h after learning were without effect.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 530491     DOI: 10.1016/0304-3940(79)95346-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats.

Authors:  Nicolas Pelisch; Naohisa Hosomi; Masaki Ueno; Daisuke Nakano; Hirofumi Hitomi; Masaki Mogi; Kenji Shimada; Hiroyuki Kobori; Masatsugu Horiuchi; Haruhiko Sakamoto; Masayasu Matsumoto; Masakazu Kohno; Akira Nishiyama
Journal:  Am J Hypertens       Date:  2010-12-16       Impact factor: 2.689

2.  Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism.

Authors:  Daniel S Kerr; Lia R M Bevilaqua; Juliana S Bonini; Janine I Rossato; Cristiano A Köhler; Jorge H Medina; Iván Izquierdo; Martín Cammarota
Journal:  Psychopharmacology (Berl)       Date:  2004-11-17       Impact factor: 4.530

3.  Brain Angiotensin II AT1 receptors are involved in the acute and long-term amphetamine-induced neurocognitive alterations.

Authors:  Natalia Andrea Marchese; Emilce Artur de laVillarmois; Osvaldo Martin Basmadjian; Mariela Fernanda Perez; Gustavo Baiardi; Claudia Bregonzio
Journal:  Psychopharmacology (Berl)       Date:  2015-11-28       Impact factor: 4.530

4.  Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 5.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

6.  Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats.

Authors:  D Baranowska; J J Braszko; K Wiśniewski
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Angiotensin II in the hippocampus. A histochemical and electrophysiological study.

Authors:  H L Haas; D Felix; M R Celio; T Inagami
Journal:  Experientia       Date:  1980-12-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.